We report how cerebrospinal fluid (CSF) circulating tumor DNA (ctDNA) clarified therapeutic direction in EGFR-mutated non-small-cell lung cancer (NSCLC) with leptomeningeal involvement. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.